Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
An update from Little Green Pharma Ltd. ( (AU:LGP) ) is now available.
Little Green Pharma Ltd. has announced an investor webinar, where CEO Paul Long will discuss the company’s impressive December quarterly results, including a $9.5 million revenue and a record sales month of $3.6 million in December. The presentation will also cover the company’s strategic expansion into European and UK markets and the acquisition of the Australian medicinal cannabis distribution company, Health House, highlighting its growth and competitive positioning in the industry.
More about Little Green Pharma Ltd.
Little Green Pharma is a global, vertically integrated medicinal cannabis business, engaging in cultivation, production, manufacturing, and distribution. The company operates three global production sites, including facilities in Denmark and Western Australia, and focuses on supplying medical-grade cannabis products to Australian, European, and other international markets. It emphasizes patient access, education, and innovative delivery systems in the emerging global medicinal cannabis market.
Average Trading Volume: 140,111
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$36.34M
See more data about LGP stock on TipRanks’ Stock Analysis page.
